表观遗传调节器为SCLC可塑性打开了大门
Margaret C Weber1, Luke T Izzo1, Trudy G Oliver1
1Department of Pharmacology & Cancer Biology, Duke University, Durham, North Carolina.
Cancer research
|September 27, 2023
概括
在小细胞肺癌 (SCLC) 中KDM6A的损失通过改变色素可访问性来促进分子亚型之间的可塑性. 这种表观遗传调节突出显示了组织素甲基化作为SCLC治疗耐药性的关键因素.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有侵略性的神经内分泌瘤,治疗选择有限,预后不佳.
- SCLC表现出显著的分子可塑性,在由ASCL1和NEUROD1等转录因子定义的亚型之间过渡,影响治疗反应.
- 虽然已知MYC驱动ASCL1-to-NEUROD1过渡,但控制SCLC可塑性的其他机制尚不清楚.
研究的目的:
- 为了研究KDM6A的作用,一个组织素 lysine 脱甲基酶,在调节SCLC的可塑性.
- 探索SCLC在分子状态之间过渡的能力背后的表观遗传机制.
- 通过了解SCLC的可塑性,开发新的治疗策略.
主要方法:
- 利用基因工程的SCLC与KDM6A损失的小鼠模型.
- 分析了染色质可访问性和表观遗传景观.
- 描述了KDM6A损失对SCLC分子亚型和活体可塑性的影响.
主要成果:
- 在SCLC中KDM6A损失显著改变了染色质可访问性.
- 在体内,KDM6A的丧失增加了ASCL1-to-NEUROD1可塑性的潜力.
- 通过表观遗传景观特征化,鉴定出基因组甲基化是SCLC可塑性的关键调节剂.
结论:
- KDM6A损失是SCLC可塑性的新型驱动因素,影响其治疗脆弱性.
- 表观遗传修饰,特别是基因组甲基化,在调节SCLC可塑性方面起着至关重要的作用.
- 这些发现为SCLC可塑性研究提供了新模式,并确定了改善疗法的潜在表观遗传点.
相关概念视频
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K


